Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Open Access
- 1 October 2009
- journal article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 8 (10), 2296-2307
- https://doi.org/10.1074/mcp.m800529-mcp200
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnosticsProteomics – Clinical Applications, 2008
- Urinary Proteomics in Diabetes and CKDJournal of the American Society of Nephrology, 2008
- Urinary Proteomic Biomarkers in Coronary Artery DiseaseMolecular & Cellular Proteomics, 2008
- Performance Characteristics of Electron Transfer Dissociation Mass SpectrometryMolecular & Cellular Proteomics, 2007
- High‐resolution proteome/peptidome analysis of peptides and low‐molecular‐weight proteins in urineProteomics – Clinical Applications, 2007
- Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface‐enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometryRapid Communications in Mass Spectrometry, 2003
- Treatment of ANCA-Associated VasculitisNew England Journal of Medicine, 2003
- Endothelial tissue factor stimulation by proteinase 3 and elastaseClinical and Experimental Immunology, 2001
- Complexed plasma elastase as an in vivo marker for leukocyte activation in antineutrophil cytoplasmic antibody‐associated vasculitisArthritis & Rheumatism, 1997
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994